Ga-68 PSMA-11 PET/MRI Superior to Multiparametric MRI in Prostate Cancer Detection
Thirty-two men participated in the retrospective study.
The sensitivity of gallium 68 (68Ga)–labeled prostate-specific membrane antigen–11 PET/MRI in the detection of prostate cancer is better than that of multiparametric MRI, according to a study published online in the journal Radiology.
Researchers from the University of California, San Francisco, performed a retrospective study to compare the diagnostic accuracy of 68Ga–labeled prostate-specific membrane antigen (PSMA)–11 PET/MRI with that of multiparametric MRI in the detection of prostate cancer.
Thirty-two men, median age 68 years, participated in the trial. All had undergone simultaneous 68Ga-PSMA-11 PET/MRI before radical prostatectomy between December 2015 and June 2017. The reference standard was whole-mount pathologic examination. Readers were blinded to radiologic and pathologic findings. Tumor localization was based on 30 anatomic regions.
The results showed that the region-specific sensitivities of PET/MRI was 74% and multiparametric MRI was 50% with the alternative neighboring approach. It was 73% for PET/MRI and 69% for multiparametric MRI with the population-averaged generalized estimating equation. Region-specific specificity of PET/MRI was similar to that of multiparametric MRI with the alternative neighboring approach (88% vs 90%) and in population-averaged estimates (70% vs 70%). SUVmax was associated with a Gleason score of 7 and higher.
The researchers concluded that the sensitivity of gallium 68–labeled prostate-specific membrane antigen–11 PET/MRI provided better results in the prostate cancer detection than did multiparametric MRI.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 3rd 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 3rd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 3rd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 3rd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 3rd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
